Prediction of drug metabolism and interactions on the basis of in vitro investigations
- PMID: 15733211
- DOI: 10.1111/j.1742-7843.2005.pto960305.x
Prediction of drug metabolism and interactions on the basis of in vitro investigations
Abstract
Drug metabolism profoundly affects drug action, because almost all drugs are metabolised in the body and thus their concentrations and elimination rates are dependent on metabolic activity. Drug metabolism contributes substantially to interindividual differences in drug response and is also often involved in drug interactions, resulting in either therapeutic failure or adverse effects. Knowledge about the metabolism of a new chemical entity and its affinity to drug-metabolising enzymes helps in the drug development process by providing important information for the selection of a lead compound from among a number of substances pharmacologically equally effective in their therapeutic response. In drug development protocols, metabolism characteristics should be assessed very early during the development process. This has been made possible by the advances made especially in analytical capabilities and in in vitro technologies that are employed to predict in vivo metabolite profile, pharmacokinetic parameters and drug-drug interaction potential.
Similar articles
-
Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.Chem Biol Interact. 2007 May 20;168(1):30-50. doi: 10.1016/j.cbi.2006.10.013. Epub 2006 Nov 28. Chem Biol Interact. 2007. PMID: 17134688 Review.
-
Emerging role of drug interaction studies in drug development: the good, the bad, and the unknown.Psychopharmacol Bull. 2001 Autumn;35(4):80-93. Psychopharmacol Bull. 2001. PMID: 12397858 Review.
-
Drug interactions evaluation: an integrated part of risk assessment of therapeutics.Toxicol Appl Pharmacol. 2010 Mar 1;243(2):134-45. doi: 10.1016/j.taap.2009.12.016. Epub 2010 Jan 4. Toxicol Appl Pharmacol. 2010. PMID: 20045016 Review.
-
The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.Am Fam Physician. 2007 Aug 1;76(3):391-6. Am Fam Physician. 2007. PMID: 17708140 Review.
-
Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment.Xenobiotica. 2007 Oct-Nov;37(10-11):1225-56. doi: 10.1080/00498250701670945. Xenobiotica. 2007. PMID: 17968744 Review.
Cited by
-
Coumarin-Based Profluorescent and Fluorescent Substrates for Determining Xenobiotic-Metabolizing Enzyme Activities In Vitro.Int J Mol Sci. 2020 Jul 1;21(13):4708. doi: 10.3390/ijms21134708. Int J Mol Sci. 2020. PMID: 32630278 Free PMC article. Review.
-
Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4.Intensive Care Med. 2009 Mar;35(3):417-29. doi: 10.1007/s00134-008-1384-1. Epub 2009 Jan 9. Intensive Care Med. 2009. PMID: 19132343 Review.
-
Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation.Eur J Drug Metab Pharmacokinet. 2021 Mar;46(2):173-183. doi: 10.1007/s13318-020-00666-w. Epub 2020 Dec 19. Eur J Drug Metab Pharmacokinet. 2021. PMID: 33340340
-
Biophysical effects, safety and efficacy of raspberry leaf use in pregnancy: a systematic integrative review.BMC Complement Med Ther. 2021 Feb 9;21(1):56. doi: 10.1186/s12906-021-03230-4. BMC Complement Med Ther. 2021. PMID: 33563275 Free PMC article.
-
Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation.Cancer Chemother Pharmacol. 2016 Dec;78(6):1225-1235. doi: 10.1007/s00280-016-3181-9. Epub 2016 Oct 24. Cancer Chemother Pharmacol. 2016. PMID: 27778071 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical